Dr. Joshua A. Rezkalla, MD

Dr. Rezkalla practices at Mayo Clinic Health System Mankato Hospital in Mankato, Minnesota.

Dr. Rezkalla's NPI, 1740711829, was assigned on March 21, 2017. Dr. Rezkalla graduated from Sanford School of Medicine of University of South Dakota in 2017. Dr. Rezkalla holds Minnesota license 69137.

Dr. Rezkalla's primary practice is Mayo Clinic Health System Mankato Hospital, at 1025 Marsh St, Mankato, MN 56001 in Blue Earth County. The practice phone is (507) 594-6449.

Dr. Rezkalla's primary practice is Mayo Clinic Health System Mankato Hospital in Mankato, Minnesota. Dr. Rezkalla is also affiliated with Mayo Clinic Health System in Mankato. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Rezkalla to 1 more hospital, 4 medical groups, 2 group practices and clinics and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rezkalla practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Rezkalla's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Rezkalla's licenses on file in 3 states: Minnesota, California and Wisconsin.

CMS data shows 42 Medicare services from Dr. Rezkalla across 1 procedure code in 2024, all of them office visits, for 90 Medicare patients. Medicare paid $7,260 for them. Every service was in an office.

CMS counts 90 Medicare patients who saw Dr. Rezkalla in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rezkalla's median patient age at 73, with 30% women.

In 2024, Dr. Rezkalla wrote 197 Medicare Part D claims for 80 patients. 81% of them were for generic drugs. CMS names the drug for 141 of them, across 7 drugs with 11 or more claims each, at $22,490 in total drug cost. In 2023, CMS named 71 claims across 4 drugs.

Dr. Rezkalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Rezkalla, published from 2022 to 2024. 2023 was the busiest year, with 9. The most frequent topics are Cardiac Catheterization and Heart Valve Prosthesis Implantation. Dr. Rezkalla has published most often in JACC Case Rep. Dr. Rezkalla's most frequent co-authors are Mackram F. Eleid, MD, Helayna Abraham, MD and Stephen M. Ansell, MD.

CMS Open Payments shows 19 general payments to Dr. Rezkalla from 6 drug and device companies from 2022 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 60% of the total. Medtronic, Inc. paid the most, $3,293.

Dr. Rezkalla graduated from Sanford School of Medicine of University of South Dakota in 2017.